Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R K Kambhampati

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Clinical Psychopharmacology|June 1, 1989
Prolonged fever without extrapyramidal symptoms during neuroleptic treatmentM S Keshavan, R K Kambhampati
The British Journal of Psychiatry : the Journal of Mental Science|January 1, 1994
Creatine kinase elevations with clozapineM S Keshavan, J Stecker, R K Kambhampati
The Journal of Clinical Psychiatry|July 1, 1992
Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?H Levin, K N Chengappa, R K Kambhampati, et al.
The Journal of Clinical Psychiatry|August 8, 2001
Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitor antidepressantsK N Chengappa, R K Kambhampati, K Perkins, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Clinical Psychopharmacology|June 1, 1989
Prolonged fever without extrapyramidal symptoms during neuroleptic treatmentM S Keshavan, R K Kambhampati
The British Journal of Psychiatry : the Journal of Mental Science|January 1, 1994
Creatine kinase elevations with clozapineM S Keshavan, J Stecker, R K Kambhampati
The Journal of Clinical Psychiatry|July 1, 1992
Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?H Levin, K N Chengappa, R K Kambhampati, et al.
The Journal of Clinical Psychiatry|August 8, 2001
Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitor antidepressantsK N Chengappa, R K Kambhampati, K Perkins, et al.
Pageof 1